172@29@16@13!~!172@29@0@53!~!|company-article|lupin|news|L!~!|stocks|company_info|stock_news.php
Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin

Lupin

BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 14, 11:56
1014.55
84.15 (9.04%)
VOLUME 508,619
LIVE
NSE
Aug 14, 11:56
1014.95
84.45 (9.08%)
VOLUME 14,214,898
News on Lupin
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Lupin; target of Rs 979; KRChoksey

3.30 pm | 12 Aug 2020 |  Source: Moneycontrol.com

KRChoksey is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 979 in its research report dated August 11, 2020....

Buy Lupin; target of Rs 1015: Motilal Oswal

6.59 pm | 11 Aug 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Lupin recommended buy rating on the stock with a target price of Rs 1015 in its research report dated August 08, 2020....

Hold Lupin; target of Rs 905: Emkay Global Financial

4.17 pm | 11 Aug 2020 |  Source: Moneycontrol.com

Emkay Global Financial recommended hold rating on Lupin with a target price of Rs 905 in its research report dated August 08, 2020....

Buy Lupin; target of Rs 980: HDFC Securities

4.16 pm | 11 Aug 2020 |  Source: Moneycontrol.com

HDFC Securities is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 980 in its research report dated August 10, 2020...

Lupin first company to shift manufacturing of some drugs from India to US after Trump’s ‘Buy American’ order

9.03 pm | 10 Aug 2020 |  Source: Moneycontrol.com

CEO Vinita Gupta does not name the drugs. Analysts say move will not have much effect on Indian pharma sector. Gupta says US business was down 26 perc...

Buy Lupin; target of Rs 1030: ICICI Direct

1.02 pm | 10 Aug 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated August 09, 2020....

Lupin: Execution for US portfolio a key monitorable

10.47 am | 10 Aug 2020 |  Source: Moneycontrol.com

Lupin's guidance for the portfolio rollout in the US market is encouraging. New launches and an improving market share in Levothyroxine are expec...

Lupin Consolidated June 2020 Net Sales at Rs 3,527.86 crore, down 20.15% Y-o-Y

9.44 am | 10 Aug 2020 |  Source: Moneycontrol.com

NULL...

Lupin Standalone June 2020 Net Sales at Rs 2,695.08 crore, down 8.36% Y-o-Y

9.33 am | 10 Aug 2020 |  Source: Moneycontrol.com

NULL...

Sell Lupin; target of Rs 753: Dolat Capital

9.13 pm | 09 Aug 2020 |  Source: Moneycontrol.com

Dolat Capital is bearish on Lupin has recommended sell rating on the stock with a target price of Rs 753 in its research report dated August 08, 2020....

Lupin, Sun Pharma recall drugs in the US market

2.00 pm | 09 Aug 2020 |  Source: PTI

The Mumbai-based drug maker Lupin is recalling 11,688 bottles of Lisinopril tablets USP, 10 mg, which is used to treat high blood pressure, in the US ...

Buy Lupin; target of Rs 1001: Prabhudas Lilladher

9.03 am | 09 Aug 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1001 in its research report dated August 08,...

Hold Lupin; target of Rs 965: Sharekhan

4.36 pm | 08 Aug 2020 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Lupin with a target price of Rs 965 in its research report dated August 07, 2020....

Lupin shares fall 6% after Q1 net profit falls 60% YoY fall

11.17 am | 07 Aug 2020 |  Source: Moneycontrol.com

Lupin's Q1FY21 net profit from continuing operations stood at Rs 106.9 crore against Rs 264.7 crore in Q1FY20, the company said on August 6....

Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet

12.55 pm | 05 Aug 2020 |  Source: PTI

Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filing....

Lupin gets USFDA nod for generic diabetes drug

4.15 pm | 04 Aug 2020 |  Source: PTI

The Mumbai-based company has received a tentative approval from the US Food and Drug Administration (USFDA) for its Empagliflozin tablets, in strength...

Lupin recalls 35,928 bottles of generic antibiotic drug in the US

12.57 pm | 02 Aug 2020 |  Source: PTI

As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), the Mumbai-based company is recalling Cefdinir for oral suspensio...

Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market

8.05 pm | 26 Jul 2020 |  Source: PTI

As per the USFDA, the companies are recalling the product due to deviation from the current good manufacturing practices (CGMP)....

Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market

2.13 pm | 26 Jul 2020 |  Source: PTI

As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Lupin is recalling 4,92,858 bottles of Metformin Hydrochloride ex...

Sell Lupin; target of Rs 753: Dolat Capital

12.50 pm | 26 Jul 2020 |  Source: Moneycontrol.com

Dolat Capital is bearish on Lupin has recommended sell rating on the stock with a target price of Rs 753 in its research report dated July 24, 2020....

1 2
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.